Key Takeaways
- • Capacitate, Inc. has filed four non-provisional patent applications covering its Self-Care Operating System (SCOS), with founder and CEO Edmund L. Valentine named as inventor and the applications assigned to Capacitate, according to a Business Wire release.
- • SCOS is designed to connect health-risk detection with clinically supervised intervention and is described as a governed healthcare execution layer; the applications join Capacitate's issued U.S. Patent No. 10,660,824.
- • Valentine forecasts that healthcare platformization, the integration of fragmented technologies, clinical services and financing into coordinated digital ecosystems, will be the most important structural transformation of healthcare over the next decade.
- • CMS projects U.S. national healthcare expenditures will rise from approximately $5.3 trillion in 2024 to nearly $9 trillion by 2034, per the release.
- • The company is developing its platform and engaging prospective pilot partners to validate clinical, operational and economic value; the release does not disclose funding amounts or commercial timelines.
Summary
Capacitate, Inc., a West Palm Beach, Florida-based healthcare technology company, has filed four non-provisional patent applications covering its Self-Care Operating System (SCOS), according to a Business Wire announcement. Edmund L. Valentine, the company's founder and CEO, is the named inventor, and the applications are assigned to Capacitate. The filings join the company's issued U.S. Patent No. 10,660,824. The company says SCOS has been architected and is now in development.
The filings follow Valentine's remarks in October at the Global Family Office Investment Summit in Miami, where he forecast that healthcare platformization will be the most important structural transformation of healthcare over the next decade. Valentine, author of *Multi-Trillion Dollar U.S. Healthcare to 2035: Gold Rush II* (published January 2026), argues that healthcare is following a development pattern seen in other digital industries: fragmentation, integration, then platformization. He expects multiple interoperable platforms rather than a single universal system.
The release cites CMS projections that U.S. national healthcare expenditures will grow from roughly $5.3 trillion in 2024 to nearly $9 trillion by 2034. It also notes that CMS launched its ten-year ACCESS Model in July 2026, which tests outcomes-aligned payments for technology-supported chronic care. Valentine characterizes this as an early sign of alignment among technology, clinical delivery and financial incentives. He acknowledges that clinical accountability, interoperability, patient privacy, reimbursement alignment and demonstrated economic value remain significant barriers.
According to the company, SCOS is intended to coordinate existing healthcare, monitoring and reimbursement systems while incorporating clinical oversight, authorization, privacy safeguards and auditable outcomes. Capacitate is engaging prospective pilot partners to validate the approach. The release is promotional in nature and does not disclose financing, deployment dates or independent validation of the technology.
The filings follow Valentine's remarks in October at the Global Family Office Investment Summit in Miami, where he forecast that healthcare platformization will be the most important structural transformation of healthcare over the next decade. Valentine, author of *Multi-Trillion Dollar U.S. Healthcare to 2035: Gold Rush II* (published January 2026), argues that healthcare is following a development pattern seen in other digital industries: fragmentation, integration, then platformization. He expects multiple interoperable platforms rather than a single universal system.
The release cites CMS projections that U.S. national healthcare expenditures will grow from roughly $5.3 trillion in 2024 to nearly $9 trillion by 2034. It also notes that CMS launched its ten-year ACCESS Model in July 2026, which tests outcomes-aligned payments for technology-supported chronic care. Valentine characterizes this as an early sign of alignment among technology, clinical delivery and financial incentives. He acknowledges that clinical accountability, interoperability, patient privacy, reimbursement alignment and demonstrated economic value remain significant barriers.
According to the company, SCOS is intended to coordinate existing healthcare, monitoring and reimbursement systems while incorporating clinical oversight, authorization, privacy safeguards and auditable outcomes. Capacitate is engaging prospective pilot partners to validate the approach. The release is promotional in nature and does not disclose financing, deployment dates or independent validation of the technology.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.